Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Rubrik, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
FY2026
Revenue
600
628
887
1,316
Cost of revenue
182
145
266
262
Gross profit
418
483
621
1,054
Research and development
175
207
532
374
Selling and marketing
418
483
868
769
General and administrative
86.8
100
356
257
Operating expenses
679
789
1,755
1,400
Operating income
-262
-307
-1,134
-345
Interest expense
11.7
30.3
41.3
17.2
Interest income
5.14
11.2
25.4
52.2
Other non-operating income
-1.03
-1.88
1.48
-9.33
Pre-tax income
-269
-327
-1,148
-326
Income tax
8.6
26.7
6.37
22.4
Net income
-278
-354
-1,155
-349
EBITDA
-239
-282
-1,105
-308
EPS, basic
-4.66
-5.84
-7.48
-1.78
EPS, diluted
-4.66
-5.84
-7.48
-1.78
Shares, basic (weighted)
59.6
60.6
154
196
Shares, diluted (weighted)
59.6
60.6
154
196
Balance sheet
FY2023
FY2025
FY2025
FY2026
Cash and equivalents
141
130
186
380
Short-term investments
149
519
1,296
Receivables
134
178
257
Inventory
4.81
4.18
5.68
Other current assets
7.98
16.4
14.9
Total current assets
549
1,078
2,224
Property, plant and equipment
47.9
53.2
83.8
Lease right-of-use assets
29.8
25.9
32.9
Goodwill
100
100
200
Other non-current assets
62.9
59.3
102
Total assets
874
1,423
2,767
Accounts payable
6.87
10.4
15.3
Accrued liabilities
123
163
230
Deferred revenue
526
777
1,069
Total current liabilities
656
950
1,314
Long-term debt
287
322
Lease liabilities
22.3
18.4
24.3
Other non-current liabilities
55.1
61.8
64.8
Total liabilities
1,578
1,977
3,286
Total debt
287
322
Paid-in capital
265
2,292
2,663
Retained earnings
-1,683
-2,837
-3,186
Other comprehensive income
-2.24
-8.24
3.73
Shareholders' equity
-1,087
-1,419
-554
-520
Total equity
-1,087
-1,419
-554
-520
Total liabilities and equity
874
1,423
2,767
Cash flow statement
FY2023
FY2025
FY2025
FY2026
Net income
-278
-354
-1,155
-349
Depreciation and amortization
22.4
24.3
28.9
37.1
Stock-based compensation
6.95
5.72
914
329
Deferred income tax
4.45
1.94
1.24
4.01
Change in receivables
8.75
17.2
-44.3
-79.8
Change in payables
-7.49
-1.01
4.48
4.48
Cash from operations
19.3
-4.52
48.2
283
Capital expenditures
-25
-12.3
-16.9
-29.6
Acquisitions
0
-90.3
0
-21.3
Purchases of investments
-219
-246
-797
-1,472
Sales and maturities of investments
92.2
255
407
708
Cash from investing
-125
-93.6
-383
-830
Debt repaid
0
0
-330
Stock issued
3.82
3.38
8.52
4.08
Share buybacks
-0.01
0
0
Cash from financing
172
95.9
398
737
Exchange rate effect
-1.01
-1.36
-6.27
9.83
Net change in cash
64.9
-3.55
56.5
199
Free cash flow
-5.73
-16.9
31.3
253
Interest paid
4.95
9.52
15
11.8
Income taxes paid
6.02
5.05
11.9
12
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $109.55 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
80.2%
Gross profit / revenue.
Operating margin
-18.3%
Operating income / revenue.
EBITDA margin
-16.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-14.6%
Pre-tax income / revenue.
Net margin
-16.5%
Net income / revenue.
FCF margin
19.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
21.9%
Cash from operations / revenue.
Return on assets (ROA)
-8.9%
Net income / average total assets.
R&D / revenue
28.6%
Research and development expense / revenue.
Stock-based pay / revenue
22.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
2.2%
Capital expenditures / revenue.
D&A / revenue
2.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
48.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
29.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
69.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
36.1%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
486.6%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y
144.8%
Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y
708.1%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
94.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
27.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
48.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.64x
Current assets / current liabilities.
Quick ratio
1.46x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.26x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
9.8%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.23
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$7.48
Revenue / diluted weighted shares.
FCF per share
$1.47
Free cash flow / diluted weighted shares.
Operating cash flow per share
$1.64
Cash from operations / diluted weighted shares.
Book value per share
-$2.42
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
14.6x
Market cap / revenue.
P/FCF
74.2x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
66.9x
Market cap / cash from operations, when positive.
EV/Sales
13.5x
Enterprise value / revenue.
EV/FCF
68.4x
Enterprise value / free cash flow, when both are positive.
FCF yield
1.3%
Free cash flow / market cap.
Earnings yield
-1.1%
Net income / market cap (the inverse of P/E).
What was Rubrik, Inc.'s revenue in fiscal 2026?
Rubrik, Inc. reported revenue of $1.32B for fiscal 2026, 48.5% higher than the year before.
Was Rubrik, Inc. profitable in fiscal 2026?
No. It reported a net loss of $348.8M.
How much free cash flow did Rubrik, Inc. generate in fiscal 2026?
Cash from operations of $282.9M minus capital expenditures of $29.6M left free cash flow of $253.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.